Suchergebnisse - "Machiels, J P"

PubPharm (136)

31

13TiP Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: methodology of phase 3 randomized trial

enthalten in: Annals of oncology | 2015

von Harrington, K. | Machiels, J. | Shin, S. | +6

32

OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck

enthalten in: Radiotherapy & oncology | 2015

von hrnrooth, E. | Clement, P. | Cupissol, D. | +17

33

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium

enthalten in: Acta clinica Belgica | 2014

von Cornelis, N. | Vermassen, T. | Schallier, D. | +9

34

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium

enthalten in: Acta clinica Belgica | 2014

von Cornelis, N. | Vermassen, T. | Schallier, D. | +9

35

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

enthalten in: British journal of anaesthesia | 2014

von Forget, P. | Bentin, C. | Machiels, J. | +3

CommentIn: Br J Anaesth. 2015 Mar;114(3):527. - PMID 25694564

36

Metastatic signet-ring cell carcinoma of unknown primary origin

enthalten in: Acta clinica Belgica | 2014

von Gregoire, C. | Muller, G. | Machiels, J. | +1

37

Metastatic signet-ring cell carcinoma of unknown primary origin

enthalten in: Acta clinica Belgica | 2014

von Gregoire, C. | Muller, G. | Machiels, J. | +1

38

Castrate-Resistant Prostate Cancer with Peritoneal Metastases Treated with Docetaxel-Based Chemotherapy

enthalten in: Urologia internationalis | 2014

von Rizk, R. | Danse, E. | Aydin, S. | +2

39

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

enthalten in: British journal of cancer | 2013

von Seront, E. | Boidot, R. | Bouzin, C. | +5

40

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours

enthalten in: The British journal of cancer | 2013

von Seront, E. | Boidot, R. | Bouzin, C. | +5